Realistic Expectations?

The goals for your operations teams are the same every year:

• Be more productive
• Reduce compliance risk
• Shorten cycle times

Can you do all that, even while cutting costs?

Fortunately, the FDA has aligned itself with the pharmaceutical industry in using technology to modernize manufacturing and laboratory testing processes. Corporate initiatives like “right-first-time” and “operational excellence” are being promoted to improve manufacturing areas. Automation enables companies to institutionalize these new initiatives.

Automation of compliance-related activities is being given higher priority. Estimates show that 70% of laboratory-based resources are focused on compliance-related functions: documenting, checking, and reporting the compliance state of every method, instrument, lab supply, and analyst involved in testing each sample. When the annual cost of an FTE is considered, the money wasted on manual paper-based activities can be overwhelming.

Proven Results!

VelQuest has a proven solution that is purpose-built to address these problems. Presented at the annual IMACS meeting, VelQuest customers like AstraZeneca, McNeil Consumer Healthcare, Bristol-Myers Squibb, and GlaxoSmithKline routinely report these benefits:

• Increased capacity by 30% without adding headcount
• Reduced investigations and rework loops by eliminating lab errors.
• Reduced data review and reporting cycle times by 50%.
• Reduced overall lab operational costs by 20%.

Interested in cutting costs and increasing productivity in your laboratory operations? Learn more about the SmartLab gmp Electronic Notebook System.